Compare SVRA & ACVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SVRA | ACVA |
|---|---|---|
| Founded | 2007 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 870.4M |
| IPO Year | 2009 | 2021 |
| Metric | SVRA | ACVA |
|---|---|---|
| Price | $5.56 | $4.33 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 12 |
| Target Price | $7.33 | ★ $11.32 |
| AVG Volume (30 Days) | 1.5M | ★ 2.3M |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 18.75 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $759,606,000.00 |
| Revenue This Year | N/A | $13.99 |
| Revenue Next Year | $430.87 | $12.62 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.22 |
| 52 Week Low | $1.89 | $4.07 |
| 52 Week High | $7.01 | $17.16 |
| Indicator | SVRA | ACVA |
|---|---|---|
| Relative Strength Index (RSI) | 55.36 | 34.57 |
| Support Level | $5.47 | N/A |
| Resistance Level | $6.10 | $5.67 |
| Average True Range (ATR) | 0.28 | 0.27 |
| MACD | 0.06 | 0.04 |
| Stochastic Oscillator | 84.27 | 27.96 |
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
ACV Auctions Inc operates a mobile platform for wholesale car auctions. It provides a digital marketplace for wholesale vehicle transactions and data services that offer transparent and accurate vehicle information for customers. Additionally, the company's marketplace platform is supported by remarketing centers in various locations throughout the United States.